Litcius/Paper detail

Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Russell E.N. Becker, Alexa Meyer, Aaron Brant, Adam C. Reese, Michael J. Biles, Kelly T. Harris, George J. Netto, Andrés Matoso, Jean Hoffman‐Censits, Noah M. Hahn, Woonyoung Choi, David J. McConkey, Phillip M. Pierorazio, Michael H. Johnson, Mark Schoenberg, Max Kates, Alex S. Baras, Trinity J. Bivalacqua

2020European Urology70 citationsDOI

Topics & Concepts

MedicineBladder cancerCystoscopyCystectomyChemotherapyExact testCisplatinCancerNeoadjuvant therapyOncologyUrologyRadiologyInternal medicineUrinary systemBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrinary Bladder and Prostate Research
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer | Litcius